PTHS Pelthos Therapeutics Inc.
NYSE · SEC CIK 1919246 · EDGAR
- Bought, last 12 months
- $1000.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $441.4K 10 sales by 5 insiders
- Filings on record
- 58 since 2024-02-23, latest 2026-07-07 17:03
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Davis Todd C | Dir | $1000.0K | — |
| Friedberg Ezra M | Dir | — | $314.3K |
| Francis Knuettel II | CFO, Treas, Secty | — | $40.3K |
| Greenleaf Peter | Dir | — | $37.5K |
| Pauls Matthew | Dir | — | $37.0K |
| Malamut Richard | Dir | — | $12.3K |
| Einhorn Andrew J. | Dir | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-07-07 17:03 | 2026-07-02 | PTHS | Friedberg Ezra M | Dir | S - Sale | $26.09 | -558 | 81.0K | -0.7% | -$14.6K |
| MT | 2026-07-07 17:03 | 2026-07-02 | PTHS | Pauls Matthew | Dir | S - Sale | $26.16 | -786 | 14.4K | -5% | -$20.6K |
| MT | 2026-07-07 17:03 | 2026-07-02 | PTHS | Greenleaf Peter | Dir | S - Sale | $26.13 | -797 | 23.9K | -3% | -$20.8K |
| MT | 2026-06-17 17:25 | 2026-06-15 | PTHS | Friedberg Ezra M | Dir | S - Sale | $27.29 | -283 | 81.6K | -0.3% | -$7,724 |
| M | 2026-06-15 17:25 | 2026-06-11 | PTHS | Davis Todd C | Dir | P - Purchase | $27.82 | +35.9K | 75.8K | +90% | +$1000.0K |
| D | 2026-05-26 19:17 | 2026-05-22 | PTHS | Francis Knuettel II | CFO, Treas, Secty | D - Sale to Iss | $0.00 | -13.9K | 19.5K | -42% | $0 |
| DI | 2026-05-26 19:17 | 2026-05-22 | PTHS | Francis Knuettel II | CFO, Treas, Secty | S - Sale | $26.84 | -1,500 | 11.3K | -12% | -$40.3K |
| T | 2026-05-18 18:11 | 2026-05-14 | PTHS | Friedberg Ezra M | Dir | F - Tax | $27.01 | -144 | 81.9K | -0.2% | -$3,889 |
| MT | 2026-04-06 17:03 | 2026-04-02 | PTHS | Malamut Richard | Dir | S - Sale | $20.92 | -590 | 27.4K | -2% | -$12.3K |
| MT | 2026-04-06 17:03 | 2026-04-02 | PTHS | Friedberg Ezra M | Dir | S - Sale | $20.92 | -558 | 82.0K | -0.7% | -$11.7K |
| MT | 2026-04-06 17:02 | 2026-04-02 | PTHS | Pauls Matthew | Dir | S - Sale | $20.92 | -786 | 15.2K | -5% | -$16.4K |
| MT | 2026-04-06 17:01 | 2026-04-02 | PTHS | Greenleaf Peter | Dir | S - Sale | $20.92 | -797 | 24.7K | -3% | -$16.7K |
| MA | 2026-04-01 17:45 | 2024-06-14+ | PTHS | Friedberg Ezra M | Dir | A - Grant | $0.00 | +28.0K | 82.6K | +51% | $0 |
| MA | 2026-04-01 17:45 | 2024-06-14+ | PTHS | Davis Todd C | Dir | A - Grant | $0.00 | +37.0K | 39.9K | +1,267% | $0 |
| MA | 2026-04-01 17:44 | 2024-06-14+ | PTHS | Malamut Richard | Dir | A - Grant | $0.00 | +28.0K | 28.0K | New | $0 |
| A | 2026-04-01 17:44 | 2025-07-02 | PTHS | Plesha Scott M. | CEO, Pres, Dir | A - Grant | $0.00 | +83.7K | 83.7K | New | $0 |
| A | 2026-04-01 17:43 | 2025-07-02 | PTHS | Greenleaf Peter | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| A | 2026-04-01 17:42 | 2025-07-02 | PTHS | Pauls Matthew | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| A | 2026-04-01 17:42 | 2025-07-02 | PTHS | Rangarao Sai | Chief Commercial Off | A - Grant | $0.00 | +30.5K | 30.5K | New | $0 |
| A | 2026-04-01 17:42 | 2025-07-02 | PTHS | Baxter Richard B | Dir | A - Grant | $0.00 | +19.1K | 19.1K | New | $0 |
| A | 2026-04-01 17:39 | 2025-07-02 | PTHS | Francis Knuettel II | CFO, Treas, Secty | A - Grant | $0.00 | +33.5K | 33.5K | New | $0 |
| 2025-12-29 | 2025-12-23 | PTHS | Einhorn Andrew J. | Dir | A - Grant | — | +12.0K | 12.0K | New | — | |
| DM | 2025-12-12 | 2025-07-02+ | PTHS | Pauls Matthew | Dir | M - OptEx | $0.00 | +10.6K | 8,493 | New | $0 |
| D | 2025-12-12 | 2025-12-10 | PTHS | Pauls Matthew | Dir | G - Gift | $0.00 | -9,542 | 1,074 | -90% | $0 |
| MI | 2025-11-26 | 2025-11-25 | PTHS | Friedberg Ezra M | Dir | S - Sale | $28.03 | -10.0K | 32.0K | -24% | -$280.3K |
| DMI | 2025-07-03 | 2025-07-01 | PTHS | Friedberg Ezra M | Dir | C - Cnv Deriv | $10.00 | +80.0K | 40.0K | New | +$800.0K |
| DI | 2025-07-03 | 2025-07-01 | PTHS | Davis Todd C | Dir, 10% | C - Cnv Deriv | $10.00 | +1.50M | 1.50M | New | +$15.00M |
| D | 2025-07-03 | 2025-07-01 | PTHS | LIGAND PHARMACEUTICALS INC | 10% | C - Cnv Deriv | $10.00 | +1.50M | 1.50M | New | +$15.00M |
| DI | 2025-07-03 | 2025-07-01 | PTHS | Francis Knuettel II | CFO | C - Cnv Deriv | $10.00 | +10.0K | 10.0K | New | +$100.0K |
| MI | 2024-09-16 | 2024-09-12+ | PTHS | Francis Knuettel II | CEO, Pres, CFO, Treas, Secty | P - Purchase | $0.97 | +5,200 | 547.7K | +1.0% | +$5,044 |
| I | 2024-09-16 | 2024-09-12 | PTHS | Malamut Richard | Dir | P - Purchase | $0.94 | +10.4K | 91.6K | +13% | +$9,776 |
| MI | 2024-09-12 | 2024-09-10+ | PTHS | Francis Knuettel II | CEO, Pres, CFO, Treas, Secty | P - Purchase | $0.9129 | +12.0K | 537.0K | +2% | +$11.0K |
| M | 2024-07-02 | 2024-06-28 | PTHS | Francis Knuettel II | CEO, Pres, CFO Treas, Secty | G - Gift | $0.00 | -20.0K | 515.5K | -4% | $0 |
| A | 2024-03-12 | 2024-02-21 | PTHS | Friedberg Ezra M | Dir | P - Purchase | $6.00 | +16.7K | 545.7K | +3% | +$100.0K |
| DMI | 2024-02-23 | 2024-02-21 | PTHS | Friedberg Ezra M | Dir | M - OptEx | $4.80 | +20.6K | 520.7K | +4% | +$99.1K |
| D | 2024-02-23 | 2024-02-21 | PTHS | Davis Todd C | Dir | M - OptEx | $4.80 | +29.2K | 29.2K | New | +$140.0K |
Purchase Sale Sale after option exercise All abbreviations